Leprosy at IPHC 2027

Leprosy, medically referred to as Hansen's disease, is a persistent infectious condition resulting from the bacterium Mycobacterium leprae. Its main impact is on the skin and peripheral nerves, resulting in the development of skin lesions and damage to nerves. Leprosy is transmitted through respiratory droplets from infected individuals, but it has a relatively low level of contagiousness. The majority of people are naturally immune to the bacterium, and effective treatment with multidrug therapy is available. The disease presents in various forms, ranging from mild and localized skin patches to severe nerve damage and deformities. Early diagnosis and treatment are crucial to prevent complications and disabilities. Leprosy has been stigmatized throughout history, contributing to social isolation and discrimination against affected individuals. However, with timely intervention and improved understanding of the disease, it is entirely curable. The World Health Organization (WHO) has made significant efforts to eliminate leprosy as a public health problem globally, focusing on early detection, treatment, and reducing stigma associated with the disease. While leprosy is relatively rare today, pockets of endemicity still exist in some regions. Public health initiatives and community education play vital roles in raising awareness about leprosy, reducing transmission, and ensuring that individuals affected by the disease receive the necessary care and support.